𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation

✍ Scribed by Nora D. Mineva; Xiaobo Wang; Sanghwa Yang; Haoqiang Ying; Zhi-Xiong J. Xiao; Michael F. Holick; Gail E. Sonenshein

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
342 KB
Volume
220
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Aberrant constitutive expression of the NF‐κB c‐Rel and RelA subunits in breast cancer cells was shown to promote their survival. Recently, we demonstrated that aggressive breast cancers constitutively express high levels of the RelB subunit, which promotes their more invasive phenotype via induction of the BCL2 gene. As these cancers are frequently resistant to therapy, here we tested the hypothesis that RelB promotes their survival. High RelB expressing Hs578T and MDA‐MB‐231 breast cancer cells were more resistant to γ‐radiation than MCF7 and ZR‐75 cells, which express lower RelB levels. Knockdown of RelB in Hs578T led to decreased survival in response to γ‐irradiation, while conversely ectopic expression of RelB in MCF7 cells protected these cells from radiation. Similar data were obtained upon treatment of Hs578T or MCF7 cells with the chemotherapeutic agent doxorubicin. High serum levels of 25‐hydroxyvitamin D are associated with decreased breast cancer risk and mortality, although, the mechanisms of its protective actions have not been fully elucidated. Treatment of Hs578T and Her‐2/neu‐driven NF639 cells with 1,25‐dihydroxyvitamin D~3~ decreased RelB/RELB gene expression and levels of pro‐survival targets Survivin, MnSOD and Bcl‐2, while increasing their sensitivity to γ‐irradiation. Thus, RelB, which promotes survival and a more highly invasive phenotype of breast cancer cells, is a target of 1,25‐dihydroxyvitamin D~3~, providing one mechanism for the observed protective role of 25‐hydroxyvitamin D in patients with breast cancer. J. Cell. Physiol. 220: 593–599, 2009. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Sensitive induction of apoptosis in brea
Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity
✍ Carina Danielsson; Ida S. Mathiasen; Sharon Y. James; Sepideh Nayeri; Claus Bret 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

The biologically active form of vitamin D 3 , the nuclear hormone 1a,25-dihydroxyvitamin D 3 (VD), is an important regulator of cellular growth, differentiation, and death. The hormone mediates its action through the activation of the transcription factor VDR, which is a member of the superfamily of

The potent anti-proliferative effect of
The potent anti-proliferative effect of 20-EPI analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity
✍ Christina Mørk Hansen; Carina Danielsson; Carsten Carlberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 458 KB 👁 1 views

The hormone I ,25-dihydroxyvitamin D3 (VD) has a potential use as an anti-tumor agent, but its clinical applications are restricted by its strong calcemic activity. This has led to the development of VD analogues with selectively increased growthinhibitory activity. One of the most potent analogues

Inhibition of serum-stimulated mitogen a
Inhibition of serum-stimulated mitogen activated protein kinase by 1α,25(OH)2-vitamin D3 in MCF-7 breast cancer cells
✍ Daniela A. Capiati; Ana M. Rossi; Gabriela Picotto; Silvia Benassati; Ricardo L. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

## Abstract 1α,25‐Dihydroxyvitamin D~3~ [1α,25(OH)~2~D~3~], the hormonally active form of vitamin D~3~, has been shown to be a potent negative growth regulator of breast cancer cells both in vitro and in vivo. 1α,25(OH)~2~D~3~ acts through two different mechanisms. In addition to regulating gene tr

Activation of rapid signaling pathways d
Activation of rapid signaling pathways does not contribute to 1α,25-dihydroxyvitamin D3-induced growth inhibition of mouse prostate epithelial progenitor cells
✍ Jia Li; James C. Fleet; Dorothy Teegarden 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract The active form of vitamin D, 1α,25‐dihydroxyvitamin D~3~ (1,25(OH)~2~D) inhibits the growth of prostate epithelial cells, however the underlying mechanisms have not been clearly delineated. In the current study, the impact of 1,25(OH)~2~D on the rapid activation of extracellular‐regula

Inhibition of proliferation and inductio
Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093)
✍ Sanna Ryhänen; Tiina Jääskeläinen; Janne T.A. Saarela; Pekka H. Mäenpää 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

1,25-Dihydroxyvitamin D3 (1,25D) is involved in the regulation of proliferation and differentiation of a variety of cell types including cancer cells. In recent years, numerous new vitamin D3 analogs have been developed in order to obtain favorable therapeutic properties. The effects of a new 20-epi